Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program

被引：8
|
作者：
Feit, Noah Z. [1 ]
Goldman, Debra A. [2 ]
Smith, Evan [3 ]
Deighan, Jenny [4 ]
Iasonos, Alexia [1 ,2 ]
Zivanovic, Oliver [3 ]
Hyman, David M. [1 ,5 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[4] Mem Sloan Kettering Ctr, Human Res Protect Program, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Early Drug Dev Serv, 1275 York Ave, New York, NY 10128 USA
来源：
JAMA ONCOLOGY | 2019年 / 5卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1001/jamaoncol.2018.7002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [41] Impact of the food and drug administration safety warnings and removal of indications for use of oral quinolones
    Tran, Phuong T.
    Antonelli, Patrick J.
    Hincapie-Castillo, Juan M.
    Winterstein, Almut G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 151 - 152
  • [42] Commercial health plans use of patient subgroup restrictions: An analysis of orphan and US Food and Drug Administration-expedited programs
    Jenkins, Nola B.
    Rucker, Julia A.
    Klimchak, Alexa C.
    Sedita, Lauren E.
    Chambers, James
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (05): : 472 - 479
  • [43] Methodology for the US food and drug administration's radionuclides in foods program
    Baratta, EJ
    [J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 1998, 236 (1-2) : 139 - 144
  • [44] Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
    Sands, Tristan T.
    Rahdari, Shahryar
    Oldham, Michael S.
    Nunes, Eduardo Caminha
    Tilton, Nicole
    Cilio, Maria Roberta
    [J]. CNS DRUGS, 2019, 33 (01) : 47 - 60
  • [45] Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
    Tristan T. Sands
    Shahryar Rahdari
    Michael S. Oldham
    Eduardo Caminha Nunes
    Nicole Tilton
    Maria Roberta Cilio
    [J]. CNS Drugs, 2019, 33 : 47 - 60
  • [46] US Food and Drug Administration (FDA) to conduct a review of the safety of orlistat
    Idris, Iskandar
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (11): : 1089 - 1089
  • [47] Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
    Sachs, Rachel E.
    Gavulic, Kyle A.
    Donohue, Julie M.
    Dusetzina, Stacie B.
    [J]. JAMA HEALTH FORUM, 2021, 2 (10): : E213177
  • [48] Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends
    Tran, Phuong T.
    Antonelli, Patrick J.
    Hincapie-Castillo, Juan M.
    Winterstein, Almut G.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (06) : 808 - 816
  • [49] Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019
    Guadamuz, Jenny S.
    Qato, Dima M.
    Alexander, G. Caleb
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (03): : 299 - 301
  • [50] US Food and Drug administration Approves Nexium for Use in Children Aged 1 to 11 Years
    Nahlen, Dawn Drennan
    [J]. NEWBORN AND INFANT NURSING REVIEWS, 2008, 8 (03) : E34 - E34
12345